Bill Summary

HB 1617 Stem Cell Therapy (2025 Session)
Stem Cell Therapy : Authorizes allopathic physicians & osteopathic physicians to perform stem cell therapy not approved by United States Food & Drug Administration; specifies requirements for stem cells that may be used by allopathic physicians & osteopathic physicians; requires allopathic physicians & osteopathic physicians to adhere to applicable current good manufacturing practices in performance of such therapies; prohibits allopathic physicians & osteopathic physicians from obtaining stem cells for therapies from facilities failing to meet certain requirements; requires allopathic physicians & osteopathic physicians to include certain terms in contracts or agreements with facilities producing stem cells for therapies; requires allopathic physicians & osteopathic physicians to include specified notice in any form of advertisement; provides requirements for such notice; requires allopathic physicians & osteopathic physicians to obtain signed consent form from patient or his or her representative before performing therapy; specifies requirements for consent form; requires Board of Medicine & Board of Osteopathic Medicine to adopt rules, respectively. Effective Date: July 1, 2025
02/28/25
HOUSE 
Filed
03/05/25
HOUSE 
Referred to Health Professions & Programs Subcommittee; Health & Human Services Committee
03/05/25
HOUSE 
Now in Health Professions & Programs Subcommittee
04/02/25
HOUSE 
Amended Notice: On Committee agenda - Health Professions & Programs Subcommittee, 04/03/25, 8:30 am, 102 H
04/03/25
HOUSE 
Favorable with CS by Health Professions & Programs Subcommittee; 16 Yeas, 0 Nays
04/03/25
HOUSE 
Committee Substitute Text (C1) Filed
04/04/25
HOUSE 
Now in Health & Human Services Committee
04/21/25
HOUSE 
On Committee agenda - Health & Human Services Committee, 04/22/25, 10:00 am, 17 H
04/22/25
HOUSE 
Favorable with CS by Health & Human Services Committee; 22 Yeas, 0 Nays
04/22/25
HOUSE 
Committee Substitute Text (C2) Filed
04/25/25
HOUSE 
Placed on Calendar, on 2nd reading
04/30/25
HOUSE 
Laid on Table, refer to CS/CS/SB 1768
1617
Filed on 02/28/25
PDF
Amendment 609531
Filed on 04/02/25
Adopted
1617C1
Filed on 04/03/25
PDF
Amendment 200921 DE
Filed on 04/21/25
Adopted
1617C2
Filed on 04/22/25
PDF
No amendments to this bill text filed.
458.3245
459.0127
Research & Reports
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.

No reports related to this bill.

Upcoming Events
Florida's most comprehensive legislative calendar. Learn more.

No events are scheduled at this time.

Press Releases
Related Press Announcements. Learn more.

No press releases related to this bill.

Features above are available to LobbyTools subscribers. Request a free demo or call (850) 915-0100 ext. 2 to learn more.